LFSC Performance — F/m Emerald Life Sciences Innovation ETF
Data updated: 2026-07-28
LFSC returned +7.60% year to date and +72.09% over one year to May 2026. Over one year the fund beat its Health Care Equity category average: $100 grew to $172, against $129 for the category. Volatility over the past 12 months was 23.74% a year. In the 12 months to May 2026 the fund took in a net $14.3M, and assets reached $105.06M.
LFSC Growth of $100
What $100 invested in F/m Emerald Life Sciences Innovation ETF grew to, compounded from monthly returns reported on SEC Form N-PORT, against the Health Care Equity category average over the same months.
| Period | LFSC | Category average |
|---|---|---|
| 1 year (Jun 2025 – May 2026) | $172 | $129 |
| Since data start (Oct 2024 – May 2026) | $158 | $112 |
LFSC Trailing Returns
Total returns to May 2026, from SEC N-PORT.
| Period | Total return |
|---|---|
| YTD | +7.60% |
| 1 year | +72.09% |
LFSC Annual Returns
Calendar-year total returns of F/m Emerald Life Sciences Innovation ETF, compounded from monthly SEC N-PORT returns. Partial years show the months covered.
| Year | Total return |
|---|---|
| 2026 (Jan–May) | +7.60% |
| 2025 | +56.55% |
| 2024 (Oct–Dec) | −6.46% |
LFSC Monthly Returns
Monthly total returns as reported on SEC Form N-PORT.
| Year | Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | −2.6% | +2.1% | −3.8% | +8.5% | +3.6% | — | — | — | — | — | — | — |
| 2025 | +11.8% | −6.1% | −8.6% | +2.5% | −0.5% | +7.3% | −1.4% | +15.1% | +6.6% | +10.5% | +15.3% | −3.4% |
| 2024 | — | — | — | — | — | — | — | — | — | −0.9% | +6.2% | −11.1% |
LFSC Risk
Risk measures from monthly returns over Jun 2025 – May 2026.
- 1-year volatility (annualised): 23.74%
- Best month: +15.35% (Nov 2025)
- Worst month: −3.81% (Mar 2026)
LFSC Fund Flows
Monthly money in and out of F/m Emerald Life Sciences Innovation ETF, from SEC Form N-PORT.
- 12-month net flow: $14.3M
- 12-month gross sales (incl. reinvestments): $79.2M
- Sales ÷ redemptions: 1.22×
| Month | Sales | Redemptions | Net flow |
|---|---|---|---|
| May 2026 | $9.2M | $9.3M | −$129K |
| Apr 2026 | $4.2M | $4.2M | −$18K |
| Mar 2026 | $8.5M | $7.2M | $1.3M |
| Feb 2026 | $9.4M | $5.1M | $4.3M |
| Jan 2026 | $8.8M | $9.8M | −$991K |
| Dec 2025 | $8.0M | $4.9M | $3.1M |
| Nov 2025 | $6.9M | $3.8M | $3.1M |
| Oct 2025 | $4.6M | $3.7M | $938K |
| Sep 2025 | $5.9M | $5.3M | $575K |
| Aug 2025 | $3.8M | $3.5M | $250K |
| Jul 2025 | $3.7M | $2.0M | $1.7M |
| Jun 2025 | $6.2M | $6.2M | $34K |
LFSC Assets Under Management
Net assets of F/m Emerald Life Sciences Innovation ETF by report date, from SEC N-PORT filings.
| Report date | Net assets |
|---|---|
| 2026-05-31 | $105.06M |
| 2026-02-28 | $95.65M |
| 2025-11-30 | $93.12M |
| 2025-08-31 | $64.58M |
| 2025-05-31 | $51.21M |
| 2025-02-28 | $52.46M |
| 2024-11-30 | $54.64M |
For information only. Not investment advice: figures are as reported in SEC filings and may contain errors or be out of date. Past performance does not guarantee future results.